Provided By GlobeNewswire
Last update: Nov 7, 2024
– Generated Record Q3’24 Net Revenue of $159.3 Million, Up 17% Year-over-Year, Driven by Record Belbuca® Revenue of $53.2 Million and Record Xtampza® ER Revenue of $49.5 Million –
Read more at globenewswire.com